OpenAI has officially released its newest AI model, GPT-5.5, on April 23, 2026, designed specifically for real work with ...

Open-source AI workflow platform surpasses 4M users and 50K daily downloads as investors back creator-first infrastructureSAN FRANCISCO, April 24, 2026 (GLOBE NEWSWIRE) -- Today, ComfyUI announced a ...

OpenAI has introduced GPT-5.5, a new model designed for real-world computing tasks including coding, research, data analysis, ...

Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically shortened life expectancy due to a disruption in muscle protein regulation.

Gear break is in full swing. Explore the latest road and gravel tech from Colnago, Zipp, iGPSPORT, and more as the season ...

Imagine telling a chatbot that your neighbor has been secretly recording your conversations. Instead of questioning the claim ...

APRA-regulated super funds are managing more than $3 trillion in retirement savings that weren’t built for the speed at which ...

Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically ...

Designing molecules is one of chemistry's most complex challenges. From life-saving drugs to advanced materials, each ...

Myofibrillar myopathy type 6 (MFM6) is a rare genetic muscle disorder that leads to severe muscle weakness and a drastically shortened life expectancy due to a disruption in muscle protein regulation.

Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically speeding up drug discovery—and, in early tests, it has already designed a ...